Literature DB >> 10532196

Pathological prognostic factors in breast cancer.

C W Elston1, I O Ellis, S E Pinder.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10532196     DOI： 10.1016/s1040-8428(99)00034-7

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  38 in total

Review 1.  Preoperative assessment of prognostic factors in breast cancer.

Authors:  H Denley; S E Pinder; C W Elston; A H Lee; I O Ellis
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

3.  Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer.

Authors:  Xuan Li; Danian Dai; Bo Chen; Hailin Tang; Xiaoming Xie; Weidong Wei
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

Review 4.  Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer.

Authors:  Ana C Gregório; Manuela Lacerda; Paulo Figueiredo; Sérgio Simões; Sérgio Dias; João Nuno Moreira
Journal:  Pathol Oncol Res       Date:  2017-09-14       Impact factor: 3.201

5.  Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction.

Authors:  M R Baneshi; P Warner; N Anderson; J Edwards; T G Cooke; J M S Bartlett
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

6.  Phosphorylated mTOR expression correlates with poor outcome in early-stage triple negative breast carcinomas.

Authors:  Shir-Hwa Ueng; Shin-Cheh Chen; Yu-Sun Chang; Swei Hsueh; Yung-Chang Lin; Hui-Ping Chien; Yun-Feng Lo; Shih-Che Shen; Chuen Hsueh
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

7.  Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.

Authors:  Zhi L Teo; Daniel J Park; Elena Provenzano; Catherine A Chatfield; Fabrice A Odefrey; Tu Nguyen-Dumont; James G Dowty; John L Hopper; Ingrid Winship; David E Goldgar; Melissa C Southey
Journal:  Breast Cancer Res       Date:  2013-02-28       Impact factor: 6.466

8.  The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.

Authors:  Zhi L Teo; Sarah D Sawyer; Paul A James; Gillian Mitchell; Alison H Trainer; Geoffrey J Lindeman; Kylie Shackleton; Linda Cicciarelli; Melissa C Southey
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

9.  Invasive breast cancer: correlation of dynamic MR features with prognostic factors.

Authors:  Botond K Szabó; Peter Aspelin; Maria Kristoffersen Wiberg; Tibor Tot; Beata Boné
Journal:  Eur Radiol       Date:  2003-07-26       Impact factor: 5.315

10.  Correlation between high resolution dynamic MR features and prognostic factors in breast cancer.

Authors:  Shin Ho Lee; Nariya Cho; Seung Ja Kim; Joo Hee Cha; Kyung Soo Cho; Eun Sook Ko; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.